nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Sumatriptan—ABCB1—ovarian cancer	0.00152	0.553	CrCbGaD
Naratriptan—Eletriptan—ABCB1—ovarian cancer	0.00123	0.447	CrCbGaD
Naratriptan—Palpitations—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Angiopathy—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Vomiting—Melphalan—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Dehydration—Epirubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Immune system disorder—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Loss of consciousness—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Liver function test abnormal—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Naratriptan—Rash—Melphalan—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Dermatitis—Melphalan—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Chills—Docetaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Cough—Paclitaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Asthenia—Vinorelbine—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Arrhythmia—Docetaxel—ovarian cancer	0.001	0.00101	CcSEcCtD
Naratriptan—Convulsion—Paclitaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—ovarian cancer	0.000999	0.001	CcSEcCtD
Naratriptan—Alopecia—Docetaxel—ovarian cancer	0.000994	0.000997	CcSEcCtD
Naratriptan—Pruritus—Vinorelbine—ovarian cancer	0.000992	0.000994	CcSEcCtD
Naratriptan—Myalgia—Paclitaxel—ovarian cancer	0.000984	0.000986	CcSEcCtD
Naratriptan—Arthralgia—Paclitaxel—ovarian cancer	0.000984	0.000986	CcSEcCtD
Naratriptan—Anxiety—Paclitaxel—ovarian cancer	0.00098	0.000983	CcSEcCtD
Naratriptan—Erythema—Docetaxel—ovarian cancer	0.000979	0.000982	CcSEcCtD
Naratriptan—Nausea—Topotecan—ovarian cancer	0.000973	0.000976	CcSEcCtD
Naratriptan—Discomfort—Paclitaxel—ovarian cancer	0.000972	0.000974	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—ovarian cancer	0.000971	0.000973	CcSEcCtD
Naratriptan—Dry mouth—Paclitaxel—ovarian cancer	0.000962	0.000965	CcSEcCtD
Naratriptan—Diarrhoea—Vinorelbine—ovarian cancer	0.000959	0.000962	CcSEcCtD
Naratriptan—Nausea—Melphalan—ovarian cancer	0.000953	0.000956	CcSEcCtD
Naratriptan—Confusional state—Paclitaxel—ovarian cancer	0.000951	0.000953	CcSEcCtD
Naratriptan—Asthma—Epirubicin—ovarian cancer	0.000948	0.00095	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—ovarian cancer	0.000944	0.000946	CcSEcCtD
Naratriptan—Oedema—Paclitaxel—ovarian cancer	0.000943	0.000945	CcSEcCtD
Naratriptan—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000943	0.000945	CcSEcCtD
Naratriptan—Muscle spasms—Docetaxel—ovarian cancer	0.000941	0.000944	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000937	0.000939	CcSEcCtD
Naratriptan—Infection—Paclitaxel—ovarian cancer	0.000937	0.000939	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—ovarian cancer	0.00093	0.000933	CcSEcCtD
Naratriptan—Shock—Paclitaxel—ovarian cancer	0.000928	0.00093	CcSEcCtD
Naratriptan—Dizziness—Vinorelbine—ovarian cancer	0.000927	0.000929	CcSEcCtD
Naratriptan—Nervous system disorder—Paclitaxel—ovarian cancer	0.000925	0.000927	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—ovarian cancer	0.000923	0.000926	CcSEcCtD
Naratriptan—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000923	0.000926	CcSEcCtD
Naratriptan—Skin disorder—Paclitaxel—ovarian cancer	0.000916	0.000918	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—ovarian cancer	0.000912	0.000914	CcSEcCtD
Naratriptan—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000911	0.000914	CcSEcCtD
Naratriptan—Anaemia—Docetaxel—ovarian cancer	0.000905	0.000908	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—ovarian cancer	0.000898	0.000901	CcSEcCtD
Naratriptan—Vomiting—Vinorelbine—ovarian cancer	0.000891	0.000894	CcSEcCtD
Naratriptan—Rash—Vinorelbine—ovarian cancer	0.000884	0.000886	CcSEcCtD
Naratriptan—Dermatitis—Vinorelbine—ovarian cancer	0.000883	0.000885	CcSEcCtD
Naratriptan—Hypotension—Paclitaxel—ovarian cancer	0.000881	0.000883	CcSEcCtD
Naratriptan—Headache—Vinorelbine—ovarian cancer	0.000878	0.000881	CcSEcCtD
Naratriptan—Syncope—Docetaxel—ovarian cancer	0.000878	0.000881	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—ovarian cancer	0.000877	0.000879	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—ovarian cancer	0.000876	0.000878	CcSEcCtD
Naratriptan—Palpitations—Docetaxel—ovarian cancer	0.000865	0.000868	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000865	0.000868	CcSEcCtD
Naratriptan—Loss of consciousness—Docetaxel—ovarian cancer	0.000861	0.000863	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000859	0.000861	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000855	0.000857	CcSEcCtD
Naratriptan—Cough—Docetaxel—ovarian cancer	0.000854	0.000857	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—ovarian cancer	0.000854	0.000857	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—ovarian cancer	0.00085	0.000852	CcSEcCtD
Naratriptan—Convulsion—Docetaxel—ovarian cancer	0.000848	0.000851	CcSEcCtD
Naratriptan—Paraesthesia—Paclitaxel—ovarian cancer	0.000847	0.000849	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—ovarian cancer	0.000845	0.000847	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—ovarian cancer	0.000843	0.000846	CcSEcCtD
Naratriptan—Dyspnoea—Paclitaxel—ovarian cancer	0.000841	0.000843	CcSEcCtD
Naratriptan—Somnolence—Paclitaxel—ovarian cancer	0.000838	0.00084	CcSEcCtD
Naratriptan—Myalgia—Docetaxel—ovarian cancer	0.000834	0.000836	CcSEcCtD
Naratriptan—Arthralgia—Docetaxel—ovarian cancer	0.000834	0.000836	CcSEcCtD
Naratriptan—Nausea—Vinorelbine—ovarian cancer	0.000833	0.000835	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000828	0.000831	CcSEcCtD
Naratriptan—Dry mouth—Docetaxel—ovarian cancer	0.000815	0.000818	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000814	0.000816	CcSEcCtD
Naratriptan—Fatigue—Paclitaxel—ovarian cancer	0.000813	0.000815	CcSEcCtD
Naratriptan—Sweating—Epirubicin—ovarian cancer	0.00081	0.000812	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—ovarian cancer	0.00081	0.000812	CcSEcCtD
Naratriptan—Constipation—Paclitaxel—ovarian cancer	0.000806	0.000808	CcSEcCtD
Naratriptan—Pain—Paclitaxel—ovarian cancer	0.000806	0.000808	CcSEcCtD
Naratriptan—Confusional state—Docetaxel—ovarian cancer	0.000806	0.000808	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000801	0.000803	CcSEcCtD
Naratriptan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000799	0.000801	CcSEcCtD
Naratriptan—Oedema—Docetaxel—ovarian cancer	0.000799	0.000801	CcSEcCtD
Naratriptan—Infection—Docetaxel—ovarian cancer	0.000794	0.000796	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—ovarian cancer	0.000793	0.000795	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000791	0.000793	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—ovarian cancer	0.000787	0.000789	CcSEcCtD
Naratriptan—Shock—Docetaxel—ovarian cancer	0.000786	0.000788	CcSEcCtD
Naratriptan—Nervous system disorder—Docetaxel—ovarian cancer	0.000784	0.000786	CcSEcCtD
Naratriptan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000782	0.000785	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—ovarian cancer	0.000782	0.000784	CcSEcCtD
Naratriptan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000777	0.000779	CcSEcCtD
Naratriptan—Skin disorder—Docetaxel—ovarian cancer	0.000776	0.000778	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—ovarian cancer	0.000772	0.000774	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000767	0.000769	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—ovarian cancer	0.000763	0.000765	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—ovarian cancer	0.000759	0.000761	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—ovarian cancer	0.000755	0.000757	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—ovarian cancer	0.00075	0.000752	CcSEcCtD
Naratriptan—Urticaria—Paclitaxel—ovarian cancer	0.000749	0.000751	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—ovarian cancer	0.000747	0.000749	CcSEcCtD
Naratriptan—Body temperature increased—Paclitaxel—ovarian cancer	0.000745	0.000747	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—ovarian cancer	0.000734	0.000736	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000728	0.00073	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—ovarian cancer	0.000718	0.00072	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—ovarian cancer	0.000715	0.000717	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—ovarian cancer	0.000712	0.000714	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—ovarian cancer	0.00071	0.000712	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—ovarian cancer	0.000707	0.000709	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—ovarian cancer	0.000706	0.000708	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—ovarian cancer	0.000704	0.000706	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—ovarian cancer	0.000702	0.000704	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000698	0.0007	CcSEcCtD
Naratriptan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000695	0.000697	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00069	0.000692	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—ovarian cancer	0.000689	0.000691	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—ovarian cancer	0.000688	0.00069	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—ovarian cancer	0.000685	0.000687	CcSEcCtD
Naratriptan—Constipation—Docetaxel—ovarian cancer	0.000683	0.000685	CcSEcCtD
Naratriptan—Pain—Docetaxel—ovarian cancer	0.000683	0.000685	CcSEcCtD
Naratriptan—Chills—Epirubicin—ovarian cancer	0.000681	0.000683	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—ovarian cancer	0.000678	0.00068	CcSEcCtD
Naratriptan—Asthenia—Paclitaxel—ovarian cancer	0.000676	0.000678	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—ovarian cancer	0.00067	0.000672	CcSEcCtD
Naratriptan—Pruritus—Paclitaxel—ovarian cancer	0.000667	0.000669	CcSEcCtD
Naratriptan—Erythema—Epirubicin—ovarian cancer	0.00066	0.000662	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—ovarian cancer	0.000659	0.00066	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—ovarian cancer	0.000655	0.000656	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—ovarian cancer	0.000652	0.000653	CcSEcCtD
Naratriptan—Diarrhoea—Paclitaxel—ovarian cancer	0.000645	0.000647	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—ovarian cancer	0.000637	0.000639	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—ovarian cancer	0.000635	0.000637	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—ovarian cancer	0.000634	0.000636	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—ovarian cancer	0.000632	0.000633	CcSEcCtD
Naratriptan—Chills—Doxorubicin—ovarian cancer	0.00063	0.000632	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—ovarian cancer	0.000627	0.000629	CcSEcCtD
Naratriptan—Dizziness—Paclitaxel—ovarian cancer	0.000623	0.000625	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—ovarian cancer	0.000622	0.000624	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—ovarian cancer	0.00062	0.000622	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000613	0.000614	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—ovarian cancer	0.000611	0.000613	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—ovarian cancer	0.00061	0.000612	CcSEcCtD
Naratriptan—Agitation—Epirubicin—ovarian cancer	0.000607	0.000609	CcSEcCtD
Naratriptan—Vomiting—Paclitaxel—ovarian cancer	0.000599	0.000601	CcSEcCtD
Naratriptan—Malaise—Epirubicin—ovarian cancer	0.000596	0.000597	CcSEcCtD
Naratriptan—Rash—Paclitaxel—ovarian cancer	0.000594	0.000596	CcSEcCtD
Naratriptan—Dermatitis—Paclitaxel—ovarian cancer	0.000594	0.000596	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—ovarian cancer	0.000593	0.000595	CcSEcCtD
Naratriptan—Syncope—Epirubicin—ovarian cancer	0.000592	0.000594	CcSEcCtD
Naratriptan—Headache—Paclitaxel—ovarian cancer	0.000591	0.000592	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—ovarian cancer	0.000589	0.00059	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—ovarian cancer	0.000588	0.000589	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—ovarian cancer	0.000584	0.000585	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—ovarian cancer	0.00058	0.000582	CcSEcCtD
Naratriptan—Cough—Epirubicin—ovarian cancer	0.000576	0.000578	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—ovarian cancer	0.000576	0.000578	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—ovarian cancer	0.000573	0.000575	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—ovarian cancer	0.000572	0.000574	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000567	0.000569	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—ovarian cancer	0.000565	0.000567	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—ovarian cancer	0.000565	0.000566	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—ovarian cancer	0.000562	0.000564	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—ovarian cancer	0.000562	0.000564	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—ovarian cancer	0.000562	0.000563	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—ovarian cancer	0.00056	0.000562	CcSEcCtD
Naratriptan—Nausea—Paclitaxel—ovarian cancer	0.00056	0.000562	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—ovarian cancer	0.000556	0.000557	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—ovarian cancer	0.000551	0.000553	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—ovarian cancer	0.00055	0.000551	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—ovarian cancer	0.000549	0.000551	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—ovarian cancer	0.000548	0.00055	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—ovarian cancer	0.000547	0.000548	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—ovarian cancer	0.000543	0.000545	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—ovarian cancer	0.00054	0.000542	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—ovarian cancer	0.000539	0.000541	CcSEcCtD
Naratriptan—Oedema—Epirubicin—ovarian cancer	0.000539	0.000541	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—ovarian cancer	0.000537	0.000539	CcSEcCtD
Naratriptan—Infection—Epirubicin—ovarian cancer	0.000535	0.000537	CcSEcCtD
Naratriptan—Cough—Doxorubicin—ovarian cancer	0.000533	0.000535	CcSEcCtD
Naratriptan—Shock—Epirubicin—ovarian cancer	0.00053	0.000532	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—ovarian cancer	0.000529	0.000531	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—ovarian cancer	0.000529	0.00053	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—ovarian cancer	0.000528	0.00053	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000528	0.000529	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—ovarian cancer	0.000524	0.000525	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000521	0.000523	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—ovarian cancer	0.00052	0.000522	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—ovarian cancer	0.00052	0.000522	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—ovarian cancer	0.000518	0.00052	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—ovarian cancer	0.000514	0.000515	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—ovarian cancer	0.000509	0.00051	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—ovarian cancer	0.000508	0.00051	CcSEcCtD
Naratriptan—Rash—Docetaxel—ovarian cancer	0.000504	0.000505	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—ovarian cancer	0.000504	0.000505	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—ovarian cancer	0.000503	0.000505	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—ovarian cancer	0.000503	0.000504	CcSEcCtD
Naratriptan—Headache—Docetaxel—ovarian cancer	0.000501	0.000502	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—ovarian cancer	0.000499	0.0005	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000499	0.0005	CcSEcCtD
Naratriptan—Infection—Doxorubicin—ovarian cancer	0.000495	0.000497	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000491	0.000492	CcSEcCtD
Naratriptan—Shock—Doxorubicin—ovarian cancer	0.000491	0.000492	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—ovarian cancer	0.000489	0.00049	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000488	0.00049	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—ovarian cancer	0.000484	0.000486	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—ovarian cancer	0.000484	0.000485	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000482	0.000483	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—ovarian cancer	0.000481	0.000482	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—ovarian cancer	0.000479	0.000481	CcSEcCtD
Naratriptan—Nausea—Docetaxel—ovarian cancer	0.000475	0.000476	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—ovarian cancer	0.000466	0.000467	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000465	0.000467	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—ovarian cancer	0.000465	0.000466	CcSEcCtD
Naratriptan—Pain—Epirubicin—ovarian cancer	0.000461	0.000462	CcSEcCtD
Naratriptan—Constipation—Epirubicin—ovarian cancer	0.000461	0.000462	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000454	0.000456	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—ovarian cancer	0.000448	0.000449	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—ovarian cancer	0.000445	0.000446	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—ovarian cancer	0.000444	0.000445	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—ovarian cancer	0.000443	0.000445	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000431	0.000432	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—ovarian cancer	0.00043	0.000431	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—ovarian cancer	0.000428	0.000429	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—ovarian cancer	0.000426	0.000428	CcSEcCtD
Naratriptan—Pain—Doxorubicin—ovarian cancer	0.000426	0.000428	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—ovarian cancer	0.000426	0.000427	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—ovarian cancer	0.000411	0.000412	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—ovarian cancer	0.000397	0.000398	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—ovarian cancer	0.000396	0.000397	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—ovarian cancer	0.000394	0.000395	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—ovarian cancer	0.000387	0.000388	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—ovarian cancer	0.000381	0.000382	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—ovarian cancer	0.000369	0.00037	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—ovarian cancer	0.000367	0.000368	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—ovarian cancer	0.000358	0.000359	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—ovarian cancer	0.000356	0.000357	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—ovarian cancer	0.000353	0.000354	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—ovarian cancer	0.000343	0.000344	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—ovarian cancer	0.000341	0.000342	CcSEcCtD
Naratriptan—Rash—Epirubicin—ovarian cancer	0.00034	0.000341	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—ovarian cancer	0.00034	0.00034	CcSEcCtD
Naratriptan—Headache—Epirubicin—ovarian cancer	0.000338	0.000339	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—ovarian cancer	0.00033	0.000331	CcSEcCtD
Naratriptan—Nausea—Epirubicin—ovarian cancer	0.00032	0.000321	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—ovarian cancer	0.000317	0.000318	CcSEcCtD
Naratriptan—Rash—Doxorubicin—ovarian cancer	0.000314	0.000315	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—ovarian cancer	0.000314	0.000315	CcSEcCtD
Naratriptan—Headache—Doxorubicin—ovarian cancer	0.000312	0.000313	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—ovarian cancer	0.000296	0.000297	CcSEcCtD
